Literature DB >> 9854161

Porphyria cutanea tarda associated with human immunodeficiency virus infection.

C Drobacheff1, C Derancourt, H Van Landuyt, D Devred, B de Wazieres, B Cribier, D Rey, J M Lang, C Grosieux, B Kalis, R Laurent.   

Abstract

Since 1987, about 60 cases of porphyria cutanea tarda (PCT) associated with human immunodeficiency virus (HIV) have been reported. The respective roles of HIV and toxic hepatic factor in PCT remain unclear. We report 10 new cases and analyse the following toxic hepatic factors: hepatitis C and B, alcoholism, drugs. The route of HIV transmission to these 10 men were: IV drugs abuse (3), homo/bisexuality (4), heterosexuality (1), and unknown (2). When PCT was diagnosed, their average age was 38 years (29-54) and the HIV-infection had been established for 4.8 years (0.33-9). Seven men had HIV-related symptoms and a CD4+ lymphocyte count below 200/mm3. Cutaneous signs and urinary porphyrin count were characteristic. Alcohol abuse was present in 8/10 patients. AST, ALT and/or gamma GT were high in 9/10 patients; 5/10 patients had HCV antibodies (4 were HCV-PCR positive). HBs antigenemia was negative among the 5/8 patients with HBV antibodies; 10/10 patients took prescribed hepatotoxic drugs. Our series confirms the presence of toxic hepatic factors in PCT of HIV-positive patients. Hepatitis C, alcoholism and hepatotoxic drug consumption seem to be triggers for the appearance of PCT in HIV-positive patients.

Entities:  

Mesh:

Year:  1998        PMID: 9854161

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  7 in total

1.  Sun, iron, alcohol and intrinsic liver disease: a recipe for failure.

Authors:  Michael J Plakke; Sarah Haseltine Van Tassel; Anthony A Donato
Journal:  BMJ Case Rep       Date:  2013-07-02

2.  Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.

Authors:  Norman G Egger; Douglas E Goeger; Deborah A Payne; Emil P Miskovsky; Steven A Weinman; Karl E Anderson
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

Review 3.  New insights into HIV-1-primary skin disorders.

Authors:  Filiberto Cedeno-Laurent; Minerva Gómez-Flores; Nora Mendez; Jesús Ancer-Rodríguez; Joseph L Bryant; Anthony A Gaspari; Jose R Trujillo
Journal:  J Int AIDS Soc       Date:  2011-01-24       Impact factor: 5.396

4.  Sequential development of psoriasis, alopecia universalis, and vitiligo vulgaris in a human immunodeficiency virus seropositive patient: A unique case report.

Authors:  Sudarshan P Gaurkar; Kirti S Parmar; Bela J Shah
Journal:  Indian J Sex Transm Dis AIDS       Date:  2014 Jul-Dec

5.  Porphyria cutanea tarda in a human immunodeficiency virus-infected patient: A rare scenario in India.

Authors:  Ramesh M Bhat; Malcolm Pinto; S Dandakeri; Srinath M Kambil
Journal:  Indian J Sex Transm Dis AIDS       Date:  2014-01

6.  Porphyria cutanea tarda associated with HFE C282Y homozygosity, iron overload, and use of a contraceptive vaginal ring.

Authors:  James C Barton; Corwin Q Edwards
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-02-17

7.  Porphyria Cutanea Tarda Associated With Acute Hemorrhagic Pancreatitis.

Authors:  Manasi Singh; Ashley Duckett; Marc Heincelman
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.